Radiographic, Clinical and Patient Outcomes in a Multicenter, Open-label Phase IV Randomized Trial of Earlier Adalimumab Introduction Therapy Versus Later Introduction as Per Standard of Care After Initial Methotrexate Failure in Early Rheumatoid Arthritis Patients
Phase of Trial: Phase IV
Latest Information Update: 07 Nov 2016
At a glance
- Drugs Adalimumab (Primary) ; Disease-modifying antirheumatics; Methotrexate
- Indications Rheumatoid arthritis
- Focus Therapeutic Use
- Acronyms RADAR
- Sponsors Abbott Laboratories; AbbVie
- 07 Jun 2017 Biomarkers information updated
- 04 Aug 2015 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 27 Jan 2015 Planned End Date changed from 1 Jul 2021 to 1 Jul 2015, according to ClinicalTrials.gov record.